Connectome-Based Prediction of Addiction Severity
Connectome-Based Prediction of Addiction Severity
批准号:
10411939
负责人:
Rickie Miglin
金额:
$4.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2023-07-30
关键词:
AddressAdultAffectiveAreaBiologicalBiological MarkersBrainCenters for Disease Control and Prevention (U.S.)ClinicalClinical assessmentsCognitiveCommunitiesComplexDataData ReportingDevelopmentDimensionsDrug AddictionEnvironmental Risk FactorEpidemicEquationEsthesiaFingerprintFunctional Magnetic Resonance ImagingFundingHumanIndividualIndividual DifferencesInterventionInterviewMachine LearningMagnetic Resonance ImagingMeasuresMethodologyMethodsModalityModelingMotivationNational Institute of Drug AbuseNatureNeurobiologyNeuropsychologyNeurosciencesOutcomePatient Self-ReportPatternProcessPublic HealthRecording of previous eventsReportingResearchRestRewardsRiskRisk FactorsSamplingSeveritiesShort-Term MemoryStressStructureSubstance Use DisorderSurveysTechnical ExpertiseTestingTrainingTraumaUnited StatesUnited States National Institutes of HealthValidationaddictionarchive dataarchived databasebiomarker performancebiopsychosocialconnectomeconnectome based predictive modelingconnectome datadesigndiscountingexperienceillicit drug useimaging approachimprovedindividualized preventioninnovationinsightknowledge integrationmeetingsmultilevel analysismultiple drug usenetwork modelsneural modelneural networkneuroimagingnovelopioid usepersonalized predictionspolysubstance useprecision medicinepredictive markerpredictive modelingprogramspsychologicrelating to nervous systemstimulant usetrait
中文摘要
7.摘要
美国目前正面临着与使用多种类型的
物质。鉴于这一公共卫生危机,迫切需要确定跨诊断、维度
物质使用障碍(SODS)的生物标志物。在临床神经科学领域,传统的,小组级别的
功能磁共振成像(FMRI)方法一直在努力识别预测的生物标志物
在样本中复制的上瘾,可能是由于方法(A)过度匹配数据和(B)检查
隔离使用不同的肥皂水。为了解决这个问题,本应用程序的第一个目标是利用最新的进展
在基于连接组的预测建模(CPM)中,一种数据驱动的机器学习方法,以识别
功能连通性的模式(“神经指纹”),可预测跨诊断、维度
在个人层面上衡量SUD严重程度。此外,与单一模式研究相反,NIDA具有
概述了检查生物、心理和心理因素之间复杂交互作用的必要性
环境领域(优先重点1),以了解SUD漏洞的实际复杂性
(优先重点3)。根据这些优先顺序,此应用程序的第二个目标是集成
将SUD相关的全脑指标转化为成瘾易感性的多水平模型,其中包括公认的
心理和环境风险因素。拟议的研究将利用收集的档案数据
作为两项独立研究的一部分(N=242)。临床评估、自我报告数据和静息状态功能磁共振
数据来自非法药物使用增加的社区成年人的不同样本,43%的人满足
终生性生活不良的标准和81%报告非法药物使用史。我们假设一个CPM派生的
神经网络将与训练样本中的SUD严重程度相关,可用于准确地
在另一个独立样本中预测SUD严重程度(目标1)。预计这将产生一个正常工作的神经
可以进一步测试和应用的模型,以对其他疾病的SUD严重程度进行高度个性化的预测,
看不见的样本。接下来,我们假设这些网络将对多方面的
成瘾易损性模型,超越公认的心理和环境风险
因素(目标2)。跨多个领域的知识集成使该应用程序能够很好地
解决SoD的现实世界复杂性,从而为在以下方面取得重大进展提供了机会
精准医学方法的发展。此F31应用程序将为
申请人在两个关键领域的培训:(A)实施机器学习所需的技术技能
分离具有预测能力的大脑网络以识别SUD严重程度的个体差异的方法
和(B)多方面模型的概念化和设计,其中纳入了多方面的因素
描述成瘾易感性的分析领域。
英文摘要
7. Abstract
The United States is currently facing an epidemic of fatalities associated with the use of multiple types of
substances. Given this public health crisis, there is an urgent need to identify transdiagnostic, dimensional
biomarkers of substance use disorders (SUDs). In the field of clinical neuroscience, traditional, group-level
functional magnetic resonance imaging (fMRI) approaches have struggled to identify predictive biomarkers of
addiction that replicate across samples, possibly due to methods that (a) overfit the data and (b) examine
different SUDs in isolation. To address this, the first objective of this application is to leverage recent advances
in connectome-based predictive modeling (CPM), a data-driven machine-learning approach, to identify
patterns of functional connectivity (“neural fingerprints”) that are predictive of a transdiagnostic, dimensional
measure of SUD severity at the individual level. Further, as opposed to single-modality research, NIDA has
outlined the need to examine the complex interactions of factors across biological, psychological, and
environmental domains (Priority Focus #1) in order to understand the real-word complexity of SUD vulnerability
(Priority Focus #3). In line with these priorities, the second objective of this application is to integrate
SUD-related whole-brain metrics into multilevel models of addiction vulnerability that include well-established
psychological and environmental risk factors. The proposed research will make use of archival data collected
as part of two independent studies (N = 242). Clinical assessments, self-report data, and resting-state fMRI
data were collected from a diverse sample of community adults, elevated on illicit drug use, with 43% meeting
criteria for a lifetime SUD and 81% reporting a history of illicit drug use. We hypothesize that a CPM-derived
neural network will emerge in relation to SUD severity in the training sample that can be used to accurately
predict SUD severity in another independent sample (Aim #1). This is expected to produce a working neural
model that can be further tested and applied to make highly-individualized predictions of SUD severity in other,
unseen samples. Next, we hypothesize that these networks will contribute unique variance to a multi-faceted
model of addiction vulnerability, above and beyond well-established psychological and environmental risk
factors (Aim #2). The integration of knowledge across multiple domains makes this application well-situated to
address the real-world complexity of SUDs, and thus presents an opportunity for significant advances towards
the development of precision medicine methods. This F31 application will provide opportunities for the
applicant’s training in two critical areas: (a) the technical skills necessary to implement machine learning
approaches to isolate brain networks with predictive power to identify individual differences in SUD severity
and (b) the conceptualization and design of multi-faceted models that incorporate factors from multiple
domains of analysis to characterize addiction vulnerability.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
海外基金